Report post Feedback

How much is Novo Nordisk A/S (NVO) stock worth?

On November 22, 2022, Novo Nordisk A/S (NYSE:NVO) stock closed at $115.38 per share. One-month return of Novo Nordisk A/S (NYSE:NVO) was 6.67% and its shares gained 5.45% of their value over the last 52 weeks. Novo Nordisk A/S (NYSE:NVO) has a market capitalization of $259.853 billion.

Does Novo Nordisk A/S (NVO) have a biopharmaceutical segment?

Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders. Find the latest Novo Nordisk A/S (NVO) stock quote, history, news and other vital information to help you with your stock trading and investing.

Should you buy NVO (NVO) stock?

There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" NVO shares. View NVO analyst ratings or view top-rated stocks.

The World's Leading Crypto Trading Platform

Get my welcome gifts